Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza
NCT07386509Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2020
- Primary completion
- Nov 2022
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fluzone Trivalent and Influenza A (H1N1) vaccine in influenza, sponsored by Washington University School of Medicine. Primary endpoint: Comparison of antibody titers at Day 28. Started Mar 2020; status: terminated.
02
Drugs
Fluzone TrivalentInfluenza A (H1N1) vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07386509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07386509.